04:56 PM EST, 12/09/2024 (MT Newswires) -- Kevin Tang, Director, on December 05, 2024, executed a purchase for 1,200,000 shares in Aurinia Pharmaceuticals ( AUPH ) for $10,822,000. Following the Form 4 filing with the SEC, Tang has control over a total of 8,429,500 shares of the company, with 8,429,500 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1600620/000141588924028661/xslF345X05/form4-12092024_091246.xml